Tempus ECG-AF vs Volta AF-Xplorer
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 60/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Tool A focuses on identifying patients at increased risk of developing atrial fibrillation within the next year, utilizing 12-lead ECG analysis for early detection. Tool B, in contrast, is an AI-assisted system designed to guide electrophysiology ablation procedures for patients already diagnosed with complex atrial fibrillation or atrial tachycardia. While both address atrial fibrillation, their distinct applications in risk stratification versus intra-procedural treatment guidance make them adjacent rather than direct competitors.
Choose Tempus ECG-AF if…
Choose Tempus ECG-AF if your primary objective is to proactively identify patients aged 65 or older who are at an increased risk of developing new-onset atrial fibrillation within the next 12 months. This tool is ideal for screening in general cardiology or geriatrics settings to enable earlier intervention and follow-up based on standard 12-lead ECG analysis.
View Tempus ECG-AF →Choose Volta AF-Xplorer if…
Choose Volta AF-Xplorer if you are an electrophysiologist seeking real-time, AI-assisted mapping and decision support during complex atrial fibrillation or atrial tachycardia ablation procedures. This system is specifically designed to guide treatment by automatically detecting and annotating dispersed electrograms intra-procedurally, enhancing the precision of ablations.
View Volta AF-Xplorer →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Tempus ECG-AF | Volta AF-Xplorer |
|---|---|---|
| Pricing | Contact vendor | Contact for pricing |
| Deployment | Software solution, integrated into healthcare facility systems with advanced cardiology algorithms. | Software, integrated with existing electrophysiology lab hardware (e.g., EP recording systems, 3D navigation systems, mapping catheters). |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Yes AI-estimated | Yes AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Tempus ECG-AF | Volta AF-Xplorer |
|---|---|---|
| Tool Name | Tempus ECG-AF | Volta AF-Xplorer |
| Primary Use Case | Analyzes 12-lead ECG recordings to identify patients aged 65 or older at increased risk of developing atrial fibrillation/flutter (AF) within the next 12 months, supporting earlier identification and follow-up. | AI-assisted mapping and decision-support system for electrophysiology ablation procedures, automatically detecting dispersed electrograms in real-time to guide treatment for complex atrial fibrillation and atrial tachycardia. |
| Target Patient Population/Conditions | Patients 65 years or older without pre-existing AF, pacemakers, ICDs, or recent cardiac surgery, at increased risk of developing AF within 12 months. | Complex atrial fibrillation and atrial tachycardia during ablation procedures. |
| Core AI Functionality | AI-based algorithm for 12-lead ECG analysis to detect signs associated with new onset Atrial Fibrillation (AF) within 12 months. | AI-assisted mapping and decision-support system for EP ablation procedures, real-time detection and annotation of dispersed electrograms (EGMs). |
| Specialties Supported | Cardiology, Geriatrics, Internal Medicine | Cardiology |
| Compatibility | Compatible with FDA authorized resting 12-lead ECGs from GE Medical Systems and Philips Medical Systems. | Compatibility with most EP recording, 3D navigation systems, and mapping catheters (including PFA catheters); Automated tagging of regions of interest (with compatible mapping systems like EnSite Xu2021). |
Videos
Demos, reviews, and walkthroughs featuring Tempus ECG-AF and Volta AF-Xplorer.
Loading videos…
Videos need JavaScript to load. Search YouTube directly →
Frequently Asked Questions
Tempus ECG-AF is designed to analyze 12-lead ECG recordings to identify patients aged 65 or older at increased risk of developing new-onset atrial fibrillation/flutter (AF) within the next 12 months, supporting earlier identification and follow-up. In contrast, Volta AF-Xplorer is an AI-assisted mapping and decision-support system used during electrophysiology ablation procedures for complex atrial fibrillation and atrial tachycardia, focusing on real-time detection of dispersed electrograms to guide treatment.
Tempus ECG-AF is intended for patients 65 years or older without pre-existing AF, pacemakers, ICDs, or recent cardiac surgery. Volta AF-Xplorer is designed to assist electrophysiologists during ablation procedures for patients with complex atrial fibrillation and atrial tachycardia.
Tempus ECG-AF is a software solution integrated into healthcare facility systems with advanced cardiology algorithms. Volta AF-Xplorer is also a software solution, but it integrates with existing electrophysiology lab hardware, including EP recording systems, 3D navigation systems, and mapping catheters.
Yes, for Tempus ECG-AF, CMS reimbursement is available with CPT codes 0764T and 0765T, assigned to APC 5734, with a Medicare rate of $128.90, effective January 1, 2025. For Volta AF-Xplorer, the provided information states to contact the vendor for pricing, and no specific reimbursement codes are mentioned.
Tempus ECG-AF is compatible with FDA authorized resting 12-lead ECGs from GE Medical Systems and Philips Medical Systems. Volta AF-Xplorer offers extended compatibility with most EP recording systems, 3D navigation systems, and mapping catheters, including PFA catheters.
Tempus ECG-AF utilizes an AI-based algorithm to analyze 12-lead ECG recordings to detect signs associated with new onset Atrial Fibrillation (AF) within 12 months. Volta AF-Xplorer provides AI-assisted real-time detection and annotation of dispersed electrograms (EGMs), automated tagging of regions of interest, and a color-coded Dispersion Indicator (Red: highly dispersed, Orange: dispersed, Blue: non-dispersed).